Artificial intelligence in medicine: mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing
BJR|Artificial Intelligence · 2024
DOI: 10.1093/bjrai/ubae003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BJR|Artificial Intelligence, 2024. Verfasst von Usman Mahmood und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, United States. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, MIDRC.
Abstract (Originalsprache)
The adoption of artificial intelligence (AI) tools in medicine poses challenges to existing clinical workflows. This commentary discusses the necessity of context-specific quality assurance (QA), emphasizing the need for robust QA measures with quality control (QC) procedures that encompass (1) acceptance testing (AT) before clinical use, (2) continuous QC monitoring, and (3) adequate user training. The discussion also covers essential components of AT and QA, illustrated with real-world examples. We also highlight what we see as the shared responsibility of manufacturers or vendors, regulators, healthcare systems, medical physicists, and clinicians to enact appropriate testing and oversight to ensure a safe and equitable transformation of medicine through AI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, United States.
- Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, United States.
- Department of Radiology, University of Michigan, Ann Arbor, MI, 48109, United States.
- Department of Radiology, University of Chicago, Chicago, IL, 60637, United States.
- Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, 20993, United States.
- Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, 85054, United States.
ORCID-Profile: Usman Mahmood, Heang-Ping Chan, Karen Drukker, Ravi K Samala, Daniel Vergara, Nicholas Petrick, Ronald M Summers, Thomas M Deserno
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- MIDRC
- The Medical Imaging and Data Resource Center
- National Institute of Biomedical Imaging and Bioengineering
- National Institutes of Health
- National Institutes of Health Clinical Center
- Massachusetts General Hospital Executive Committee on Research
Zitieren
APA
Mahmood, U., Shukla-Dave, A., Chan, H. P., Drukker, K., Samala, R. K., Chen, Q., Vergara, D., Greenspan, H., Petrick, N., Sahiner, B., Huo, Z., Summers, R. M., Cha, K. H., Tourassi, G., Deserno, T. M., Grizzard, K. T., Näppi, J. J., Yoshida, H., Regge, D., …, & Hadjiiski, L. (2024). Artificial intelligence in medicine: mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing. BJR|Artificial Intelligence. https://doi.org/10.1093/bjrai/ubae003
Vancouver
Mahmood U, Shukla-Dave A, Chan HP, Drukker K, Samala RK, Chen Q, et al. Artificial intelligence in medicine: mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing. BJR|Artificial Intelligence. 2024. doi:10.1093/bjrai/ubae003
BibTeX
@article{Mahmood2024,
author = {Mahmood, Usman and Shukla-Dave, Amita and Chan, Heang-Ping and Drukker, Karen and Samala, Ravi K and Chen, Quan and Vergara, Daniel and Greenspan, Hayit and Petrick, Nicholas and Sahiner, Berkman and Huo, Zhimin and Summers, Ronald M and Cha, Kenny H and Tourassi, Georgia and Deserno, Thomas M and Grizzard, Kevin T and Näppi, Janne J and Yoshida, Hiroyuki and Regge, Daniele and Mazurchuk, Richard and Suzuki, Kenji and Morra, Lia and Huisman, Henkjan and Armato, Samuel G and Hadjiiski, Lubomir},
title = {Artificial intelligence in medicine: mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing},
journal = {BJR|Artificial Intelligence},
year = {2024},
doi = {10.1093/bjrai/ubae003}
}
EUVIMED